Dr Robert C Farr, MD | |
700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814-4484 | |
(208) 765-1345 | |
(208) 667-9622 |
Full Name | Dr Robert C Farr |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 700 W Ironwood Dr, Coeur D Alene, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033116322 | NPI | - | NPPES |
0083130 | Medicaid | MT | |
8409252 | Medicaid | WA | |
000010006074 | Other | REGENCE BLUE SHIELD OF ID | |
58065 | Other | BLUE CROSS OF IDAHO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | M5806 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert C Farr, MD 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814-4484 Ph: (208) 765-1345 | Dr Robert C Farr, MD 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814-4484 Ph: (208) 765-1345 |
News Archive
This intriguing question is at the heart of a new study based on an "experiment of nature" being conducted by Wellcome Trust-funded researchers.
The Perelman School of Medicine at the University of Pennsylvania has launched a new program, called AAV 3.0, to create new viral vectors to find quicker and better treatments for an array of diseases. James M. Wilson, MD, PhD, a professor of Medicine and director of the Orphan Disease Center, will lead an interdisciplinary team of over 30 scientists to create this new technology platform with support provided by the University of Pennsylvania Health System.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
Researchers at Washington University School of Medicine in St. Louis will head an ambitious study of people who live exceptionally long and healthy lives to identify the factors that account for their longevity.
› Verified 2 days ago
Dr. Daniel Edward Cannon, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr Ste 278, Coeur D Alene, ID 83814 Phone: 208-625-5160 Fax: 208-625-5733 | |
Dr. Ronald J Stout, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814 Phone: 208-765-1345 Fax: 208-667-9622 | |
Dr. Ian M Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr, Suite 278, Coeur D Alene, ID 83814 Phone: 208-625-5160 Fax: 208-625-5733 |